XNK Therapeutics

0 followers


XNK Therapeutics is focused on realizing the potential in autologous NK cell therapies for cancer patients.

Industries

Headquarters

Employees

Links

Org chart

Hans Ericson
Chief Financial Officer
Stephan Meinke
Head of R&D
Michael Uhlin
Chief Scientific Officer
Julia Remnestål
Regulatory Affairs Manager
Paul Do
Head of Clinical Manufacturing and Engineering
Zahra Rajabkhani
Production Lead
Karin Mellström
Senior Project Manager